Pneumococcal Conjugate Vaccine impact assessment in Bangladesh [version 1; referees: 1 approved, 2 approved with reservations]

The study examines the impact of the introduction of 10-valent Pneumococcal Conjugate Vaccine (PCV10) into Bangladesh’s national vaccine program. PCV10 is administered to children under 1 year-old; the scheduled ages of administration are at 6, 10, and 18 weeks. The study is conducted in ~770,000 po...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Abdullah H. Baqui, Eric D. McCollum, Samir K. Saha, Arun K. Roy, Nabidul H. Chowdhury, Meagan Harrison, Abu Abdullah Mohammad Hanif, Nicole Simmons, Arif Mahmud, Nazma Begum, Salahuddin Ahmed, Ahad M. Khan, Zabed Bin Ahmed, Maksuda Islam, Dipak Mitra, Abdul Quaiyum, Miguel A. Chavez, Farhan Pervaiz, Catherine H. Miele, Holly B. Schuh, Rasheda Khanam, William Checkley, Lawrence H. Moulton, Mathuram Santosham
Format: Artigo
Idioma:Inglês
Publicat: F1000 Research Ltd 2018-04-01
Col·lecció:Gates Open Research
Accés en línia:https://gatesopenresearch.org/articles/2-21/v1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars